CADENCE PHARMACEUTICALS INC - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 4, 2011

Attached files

file filename
10-K - FORM 10-K - CADENCE PHARMACEUTICALS INCd10k.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER - CADENCE PHARMACEUTICALS INCdex321.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)AND 15D-14(A) - CADENCE PHARMACEUTICALS INCdex311.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)AND 15D-14(A) - CADENCE PHARMACEUTICALS INCdex312.htm
EX-10.11 - 2011 CORPORATE BONUS PLAN - CADENCE PHARMACEUTICALS INCdex1011.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-171396, 333-163941 and 133-138226) and Form S-3 (Nos. 333-170538, 333-161756, 33-158126 and 333-147721) of Cadence Pharmaceuticals, Inc. and in the related Prospectuses of our reports dated March 4, 2011, with respect to the financial statements, and the effectiveness of internal control over financial reporting of Cadence Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2010.

/s/ Ernst & Young LLP

San Diego, California

March 4, 2011

Stock widget

Investing forum

CADENCE PHARMACEUTICALS INC Reports